1. Predictors of the Outcome at 2 Years in Neonates With Congenital Cytomegalovirus Infection.
- Author
-
Fourgeaud, Jacques, Magny, Jean-François, Couderc, Sophie, Garcia, Patricia, Maillotte, Anne-Marie, Benard, Melinda, Pinquier, Didier, Minodier, Philippe, Astruc, Dominique, Patural, Hugues, Parat, Sophie, Guillois, Bernard, Garenne, Armelle, Guilleminot, Tiffany, Parodi, Marine, Bussières, Laurence, Ghout, Idir, Ville, Yves, and Leruez-Ville, Marianne
- Subjects
- *
ULTRASONIC encephalography , *CYTOMEGALOVIRUS disease diagnosis , *NEWBORN screening , *PREDICTIVE tests , *RISK assessment , *INFANT development , *PREDICTION models , *RECEIVER operating characteristic curves , *PLATELET count , *RESEARCH funding , *CYTOMEGALOVIRUS diseases , *AUDIOMETRY , *DESCRIPTIVE statistics , *LONGITUDINAL method , *ODDS ratio , *VERTICAL transmission (Communicable diseases) , *NEUROPSYCHOLOGICAL tests , *MEDICAL screening , *HEARING , *FIRST trimester of pregnancy , *PREGNANCY complications , *CONFIDENCE intervals , *BIOMARKERS , *SENSITIVITY & specificity (Statistics) , *DISEASE risk factors , *CHILDREN - Abstract
Background: Approximately 20% of neonates with congenital cytomegalovirus (cCMV) develop long-term sequelae. The ability to accurately predict long-term outcomes as early as the neonatal period would help to provide for appropriate parental counseling and treatment indications. With this study, we aimed to identify neonatal predictive markers of cCMV long-term outcomes. Methods: As this study's subjects, we chose neonates diagnosed with cCMV in 13 hospitals throughout France recruited from 2013 to 2017 and evaluated for at least 2 years with thorough clinical, audiology, and imaging evaluations and psychomotor development tests. Results: A total of 253 neonates were included, and 3 were later excluded because of the identification of a genetic disorder. A total of 227 were followed up for 2 years: 187/227 (82%) and 34/227 (15%) were infected after a maternal primary or nonprimary infection, respectively, 91/227 (40%) were symptomatic at birth, and 44/227 (19%) had cCMV sequelae. Maternal primary infection in the first trimester was the strongest prognosis factor (odds ratio = 38.34 [95% confidence interval, 5.02-293], P < .001). A predictive model of no risk of sequelae at 2 years of age according to normal hearing loss at birth, normal cerebral ultrasound, and normal platelet count had 98% specificity, 69% sensitivity, and 0.89 area under the curve (95% confidence interval, 0.83-0.96). Conclusions: In the studied population, children with normal hearing at birth, normal platelet count at birth, and a normal cranial ultrasound had no risk of neurologic sequelae and a low risk of delayed unilateral sensorineural hearing loss. The use of this model based on readily available neonatal markers should help clinicians establish a personalized care pathway for each cCMV neonate. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF